Welcome to our dedicated page for TACTILE SYSTEMS TECHNOLOGY SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tactile Systems Technology, Inc. filings document a Nasdaq-listed medical technology issuer with common stock registered under the ticker TCMD. Recent Form 8-K reports disclose quarterly and annual operating results, financial condition updates, acquisition-related Regulation FD materials, FDA and product-related business highlights, share repurchase authorization activity and other corporate events.
The company's proxy and governance filings cover board composition, director elections, committee assignments, executive compensation, shareholder voting matters and amendments to its certificate of incorporation. Its SEC disclosures also identify Delaware incorporation, Nasdaq listing status, capital actions and governance provisions relevant to its public-company structure.
Asbury Valerie L. reported acquisition or exercise transactions in this Form 4 filing.
TACTILE SYSTEMS TECHNOLOGY INC director Valerie L. Asbury received a grant of 6,521 shares of common stock as a stock award. These restricted stock units will vest in full on the earlier of one year from the grant date or the next annual meeting of stockholders, bringing her direct holdings to 55,343 shares.
Huggenberger Raymond reported acquisition or exercise transactions in this Form 4 filing.
TACTILE SYSTEMS TECHNOLOGY INC director Raymond Huggenberger reported a stock-based compensation award. He received 6,521 shares of Common Stock in the form of restricted stock units at a price of $0.00 per share, increasing his direct holdings to 62,841 shares.
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next annual meeting of the stockholders, aligning the director’s compensation with the company’s future performance over that period.
King Laura G. reported acquisition or exercise transactions in this Form 4 filing.
Tactile Systems Technology Inc. director Laura G. King received an equity grant of 6,521 shares of Common Stock as a compensation award. The award was made at a price of $0.00 per share and increased her directly held position to 25,569 shares.
These shares are in the form of restricted stock units that will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders, tying the award to her continued board service over that period.
Pearson Andrea reported acquisition or exercise transactions in this Form 4 filing.
Tactile Systems Technology Inc director Andrea Pearson reported an equity grant of 6,521 shares of common stock in the form of restricted stock units at no cost. Following this award, Pearson directly holds 7,373 shares. The restricted stock units will vest in full on the earlier of one year from the grant date or the date of next year’s annual meeting of stockholders.
Tactile Systems Technology director David Brent Shafer received an equity award in the form of restricted stock units. He acquired 6,521 shares of common stock on a grant or award basis at no purchase price. After this award, he directly holds 55,343 common shares. The restricted stock units will vest in full on the earlier of one year from the grant date or the date of next year's annual meeting of the stockholders.
TACTILE SYSTEMS TECHNOLOGY INC director Carmen B. Volkart received a grant of 6,521 shares of Common Stock in the form of restricted stock units on May 6, 2026. The award carries no purchase price and is a compensation-related acquisition, not an open-market trade.
These restricted stock units will vest in full on the earlier of one year from the grant date or the date of next year's annual meeting of the stockholders. Following this grant, Volkart directly holds 44,219 shares of the company’s stock.
Washington Boyd Vindell reported acquisition or exercise transactions in this Form 4 filing.
TACTILE SYSTEMS TECHNOLOGY INC director Washington Boyd Vindell received an equity award of 6,521 shares of Common Stock on May 6, 2026. The award is in the form of restricted stock units that carry no purchase price.
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of next year’s annual meeting of the stockholders. After this grant, Vindell directly holds 41,768 shares of the company’s Common Stock.
BURKE WILLIAM W reported acquisition or exercise transactions in this Form 4 filing.
Tactile Systems Technology director William W. Burke received a grant of 6,521 shares of Common Stock as a stock award. The award takes the form of restricted stock units that vest in full on the earlier of one year from the grant date or the next annual stockholder meeting. After this grant, he directly holds 55,041 shares.
Tactile Systems Technology, Inc. held its 2026 annual meeting on May 6, 2026, where stockholders elected all nine director nominees for terms running until the 2027 annual meeting. Each nominee received over 15.3 million votes in favor, with relatively few votes withheld and 3,011,527 broker non-votes for each.
Stockholders also ratified the selection of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 18,499,882 votes for and 126,747 against. In an advisory vote, stockholders approved executive compensation, and they approved an amendment to the Amended and Restated Certificate of Incorporation so directors may be removed in a manner consistent with Delaware law.
Tactile Systems Technology, Inc. reported first‑quarter 2026 revenue of $75.3 million, up 23% from $61.3 million a year earlier, driven by growth in both lymphedema and airway clearance products. Gross margin improved to 77% from 74%, but the company posted a net loss of $1.8 million, narrower than the $3.0 million loss in the prior‑year quarter.
Lymphedema products generated $62.2 million, or 83% of revenue, while airway clearance products contributed $13.0 million, or 17%. Cash was $75.0 million with no borrowings on a $40.0 million revolving credit facility, providing liquidity alongside ongoing share repurchases of $1.1 million in the quarter.
During the quarter, Tactile Systems closed the LymphaTech acquisition for $7.2 million in cash plus contingent consideration initially valued at $4.9 million, adding 3D measurement technology and $8.5 million of goodwill. The company also recorded a $1.0 million accrual tied to an agreement in principle to settle previously disclosed False Claims Act lawsuits.